Clin2
NCT07460284Possibly a fitNot yet recruiting

Drug clearance study in healthy Chinese men

Basic Science

This study looks at how a new drug (RAY1225) leaves the body after a single injection. It involves healthy volunteers to track the drug over time and understand its safety.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
8 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • Healthy men aged 18 to 55
  • Weight at least 50 kg (110 pounds)
  • Body mass index (BMI) between 20 and 35
  • Willing to use birth control for 6 months after the dose and not donate sperm
  • No recent low blood sugar episodes, major surgeries, or serious infections
  • Able to stop smoking for a week before and during the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07232758Recruiting· Phase 1
Testing HRS-2183 Safety in Healthy Adults

This trial tests a new investigational drug called HRS-2183 in healthy volunteers to see how safe it is and how the body processes it after a single dose and after multiple doses. It's a first step in studying this potential medicine.

Jinan, Shandong
NCT07788482Not yet recruiting· Phase 1
Mass balance study of a new drug in healthy adults

This study looks at how a new drug is processed by the body in healthy adults. It will help understand how the drug is absorbed, distributed, and eliminated.

Beijing, Beijing Municipality
NCT06577415Recruiting· Phase 1
Study of RAY1225 in people with reduced liver function

This study tests a new medicine called RAY1225 in people with mild or moderate liver problems compared to those with healthy livers. It helps researchers understand how the liver affects the medicine, which could lead to safer dosing.

Guangzhou, Guangdong
NCT07580794Recruiting· Phase 1
Safety Study of New Drug HSK56630 in Healthy People

This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.

Bayswater, Victoria
NCT07744828Not yet recruiting· Phase 1
How a new drug moves through the body in healthy men

This study tests a new drug to see how it is absorbed, distributed, and removed from the body. It is given as a shot to healthy men, and the results will help determine the right dose for future studies.

Auckland
NCT07516899Not yet recruiting· Phase 1
How Your Body Processes a New Experimental Drug

This study tests how a healthy male body absorbs, uses, and removes a new experimental medication. Researchers track the drug's path through your body using a special radioactive marker to understand how it works and ensure it's safe.

Wuxi, Jiangsu

Hear when a new Basic Science trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.